| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ANGPT1
|
angiopoietin 1
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARRB2
|
arrestin, beta 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGN
|
biglycan
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTTN
|
cortactin
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CYB5R4
|
cytochrome b5 reductase 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP2S1
|
cytochrome P450, family 2, subfamily S, polypeptide 1
|
|
DDOST
|
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic)
|
|
DECR1
|
2,4-dienoyl CoA reductase 1, mitochondrial
|
|
DHFR
|
dihydrofolate reductase
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUOXA1
|
dual oxidase maturation factor 1
|
|
DUOXA2
|
dual oxidase maturation factor 2
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELP3
|
elongator acetyltransferase complex subunit 3
|
|
EP300
|
E1A binding protein p300
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1
|
|
FLG
|
filaggrin
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GMPR2
|
guanosine monophosphate reductase 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
|
HBP1
|
HMG-box transcription factor 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IL12B
|
interleukin 12B
|
|
IL1B
|
interleukin 1, beta
|
|
IL22
|
interleukin 22
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INS
|
insulin
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KL
|
klotho
|
|
KNG1
|
kininogen 1
|
|
KRT18
|
keratin 18, type I
|
|
LETM1
|
leucine zipper-EF-hand containing transmembrane protein 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAT2B
|
methionine adenosyltransferase II, beta
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MPO
|
myeloperoxidase
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
NADK
|
NAD kinase
|
|
NADK2
|
NAD kinase 2, mitochondrial
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCF1C
|
neutrophil cytosolic factor 1C pseudogene
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NMRAL1
|
NmrA-like family domain containing 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX3
|
NADPH oxidase 3
|
|
NOX4
|
NADPH oxidase 4
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NSDHL
|
NAD(P) dependent steroid dehydrogenase-like
|
|
NSFL1C
|
NSFL1 (p97) cofactor (p47)
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUAK2
|
NUAK family, SNF1-like kinase, 2
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PGAM2
|
phosphoglycerate mutase 2 (muscle)
|
|
PGD
|
phosphogluconate dehydrogenase
|
|
PGF
|
placental growth factor
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAGL2
|
pleiomorphic adenoma gene-like 2
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PON2
|
paraoxonase 2
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PRDX6
|
peroxiredoxin 6
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RFK
|
riboflavin kinase
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT2
|
sirtuin 2
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC8B1
|
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
STEAP3
|
STEAP family member 3, metalloreductase
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
TIGAR
|
TP53 induced glycolysis regulatory phosphatase
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TYMS
|
thymidylate synthetase
|
|
UTS2
|
urotensin 2
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WASF1
|
WAS protein family, member 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
